Neurobehavioral abnormalities in a brain-specific NADPH-cytochrome P450 reductase knockout mouse model

Neuroscience

Volumn 218, Issue , 2012, Pages 170-180

  Fang, C ^a   Bolivar, V J ^a,b   Gu, J ^a,b   Yang, W ^a   Zeitlin, S O ^c   Ding, X ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Brain; Cytochrome P450; Fear conditioning; Memory; Mice; NADPH cytochrome P450 reductase

Indexed keywords

CYTOCHROME P450; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CONDITIONING; CONTROLLED STUDY; CYTOCHROME P450 GENE; ENZYME ACTIVITY; EXPLORATORY BEHAVIOR; FEAR; FEMALE; FOOTSHOCK; GENE; GENE DELETION; KNOCKOUT MOUSE; LEARNING; MALE; MAZE TEST; MOUSE; NEUROLOGIC DISEASE; NOCICEPTION; NONHUMAN; OPEN FIELD TEST; PAIN THRESHOLD; PRIORITY JOURNAL; SPATIAL MEMORY; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CONDITIONING, CLASSICAL; FEAR; FEMALE; MALE; MAZE LEARNING; MEMORY; MICE; MICE, KNOCKOUT; NADPH-FERRIHEMOPROTEIN REDUCTASE;

EID: 84863784286     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.05.027     Document Type: Article

References (51)

1. Black S.D., Coon M.J. P-450 cytochromes: structure and function. Adv Enzymol Relat Areas Mol Biol 1987, 60:35-87.
2. Bolivar V.J. Intrasession and intersession habituation in mice: from inbred strain variability to linkage analysis. Neurobiol Learn Mem 2009, 92:206-214.
3. Bolivar V.J., Manley K., Messer A. Exploratory activity and fear conditioning abnormalities develop early in R6/2 Huntington's disease transgenic mice. Behav Neurosci 2003, 117:1233-1242.
4. Bolivar V.J., Pooler O., Flaherty L. Inbred strain variation in contextual and cued fear conditioning behavior. Mamm Genome 2001, 12:651-656.
5. Borroni B., Archetti S., Agosti C., Akkawi N., Brambilla C., Caimi L., Caltagirone C., Di Luca M., Padovani A. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators. Neurobiol Aging 2004, 25:747-751.
6. Bourtchuladze R., Frenguelli B., Blendy J., Cioffi D., Schutz G., Silva A.J. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994, 79:59-68.
7. Burnett A.L., Johns D.G., Kriegsfeld L.J., Klein S.L., Calvin D.C., Demas G.E., Schramm L.P., Tonegawa S., Nelson R.J., Snyder S.H., Poss K.D. Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2. Nat Med 1998, 4:84-87.
8. Carola V., D'Olimpio F., Brunamonti E., Bevilacqua A., Renzi P., Mangia F. Anxiety-related behaviour in C57BL/6 BALB/c chimeric mice. Behav Brain Res 2004, 150:25-32.
9. Carola V., D'Olimpio F., Brunamonti E., Mangia F., Renzi P. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res 2002, 134:49-57.
10. Conroy J.L., Fang C., Gu J., Zeitlin S.O., Yang W., Yang J., VanAlstine M.A., Nalwalk J.W., Albrecht P.J., Mazurkiewicz J.E., Snyder-Keller A., Shan Z., Zhang S.Z., Wentland M.P., Behr M., Knapp B.I., Bidlack J.M., Zuiderveld O.P., Leurs R., Ding X., Hough L.B. Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling. Nat Neurosci 2010, 13:284-286.
11. Dineley K.T., Xia X., Bui D., Sweatt J.D., Zheng H. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem 2002, 277:22768-22780.
12. Dragatsis I., Zeitlin S. CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain. Genesis 2000, 26:133-135.
13. Eisener-Dorman A.F., Lawrence D.A., Bolivar V.J. Behavioral and genetic investigations of low exploratory behavior in Il18r1(-/-) mice: we can't always blame it on the targeted gene. Brain Behav Immun 2010, 24:1116-1125.
14. Fang C., Gu J., Xie F., Behr M., Yang W., Abel E.D., Ding X. Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity. Drug Metab Dispos 2008, 36:1722-1728.
15. Gu J., Weng Y., Zhang Q.Y., Cui H., Behr M., Wu L., Yang W., Zhang L., Ding X. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem 2003, 278:25895-25901.
16. Hagemeyer C.E., Rosenbrock H., Ditter M., Knoth R., Volk B. Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience 2003, 117:521-529.
17. Hedlund E., Gustafsson J.A., Warner M. Cytochrome P450 in the brain; a review. Curr Drug Metab 2001, 2:245-263.
18. Henderson C.J., Otto D.M., Carrie D., Magnuson M.A., McLaren A.W., Rosewell I., Wolf C.R. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J Biol Chem 2003, 278:13480-13486.
19. Hojo Y., Hattori T.A., Enami T., Furukawa A., Suzuki K., Ishii H.T., Mukai H., Morrison J.H., Janssen W.G., Kominami S., Harada N., Kimoto T., Kawato S. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc Natl Acad Sci U S A 2004, 101:865-870.
20. Hojo Y., Higo S., Ishii H., Ooishi Y., Mukai H., Murakami G., Kominami T., Kimoto T., Honma S., Poirier D., Kawato S. Comparison between hippocampus-synthesized and circulation-derived sex steroids in the hippocampus. Endocrinology 2009, 150:5106-5112.
21. Huynh D.P., Maalouf M., Silva A.J., Schweizer F.E., Pulst S.M. Dissociated fear and spatial learning in mice with deficiency of ataxin-2. PLoS One 2009, 4:e6235.
22. Kotti T.J., Ramirez D.M., Pfeiffer B.E., Huber K.M., Russell D.W. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci U S A 2006, 103:3869-3874.
23. Kretz O., Fester L., Wehrenberg U., Zhou L., Brauckmann S., Zhao S., Prange-Kiel J., Naumann T., Jarry H., Frotscher M., Rune G.M. Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci 2004, 24:5913-5921.
24. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
25. Li A.P., Kaminski D.L., Rasmussen A. Substrates of human hepatic cytochrome P450 3A4. Toxicology 1995, 104:1-8.
26. Li L., Porter T.D. Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase. Arch Biochem Biophys 2007, 461:76-84.
27. Meyer R.P., Gehlhaus M., Knoth R., Volk B. Expression and function of cytochrome p450 in brain drug metabolism. Curr Drug Metab 2007, 8:297-306.
28. Miksys S.L., Tyndale R.F. Drug-metabolizing cytochrome P450s in the brain. J Psychiatry Neurosci 2002, 27:406-415.
29. Oliveira A.M., Estevez M.A., Hawk J.D., Grimes S., Brindle P.K., Abel T. Subregion-specific p300 conditional knock-out mice exhibit long-term memory impairments. Learn Mem 2011, 18:161-169.
30. Otto D.M., Henderson C.J., Carrie D., Davey M., Gundersen T.E., Blomhoff R., Adams R.H., Tickle C., Wolf C.R. Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis. Mol Cell Biol 2003, 23:6103-6116.
31. Peleg S., Sananbenesi F., Zovoilis A., Burkhardt S., Bahari-Javan S., Agis-Balboa R.C., Cota P., Wittnam J.L., Gogol-Doering A., Opitz L., Salinas-Riester G., Dettenhofer M., Kang H., Farinelli L., Chen W., Fischer A. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010, 328:753-756.
32. Pikuleva I.A. Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos 2006, 34:513-520.
33. Pinna G., Agis-Balboa R.C., Pibiri F., Nelson M., Guidotti A., Costa E. Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem Res 2008, 33:1990-2007.
34. Porter T.D., Coon M.J. Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem 1991, 266:13469-13472.
35. Poss K.D., Thomas M.J., Ebralidze A.K., O'Dell T.J., Tonegawa S. Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice. Neuron 1995, 15:867-873.
36. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
37. Ragnauth A., Schuller A., Morgan M., Chan J., Ogawa S., Pintar J., Bodnar R.J., Pfaff D.W. Female preproenkephalin-knockout mice display altered emotional responses. Proc Natl Acad Sci U S A 2001, 98:1958-1963.
38. Rose K., Allan A., Gauldie S., Stapleton G., Dobbie L., Dott K., Martin C., Wang L., Hedlund E., Seckl J.R., Gustafsson J.A., Lathe R. Neurosteroid hydroxylase CYP7B: vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation. J Biol Chem 2001, 276:23937-23944.
39. Russell D.W., Halford R.W., Ramirez D.M., Shah R., Kotti T. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu Rev Biochem 2009, 78:1017-1040.
40. Schacter B.A., Nelson E.B., Marver H.S., Masters B.S. Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. J Biol Chem 1972, 247:3601-3607.
41. Shen A.L., O'Leary K.A., Kasper C.B. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J Biol Chem 2002, 277:6536-6541.
42. Strobel H.W., Hodgson A.V., Shen S. Cytochrome P450: structure, mechanism, and biochemistry 1995, xii. Plenum Press, New York, 652 p. P.R. Ortiz de Montellano (Ed.).
43. Strobel H.W., Thompson C.M., Antonovic L. Cytochromes P450 in brain: function and significance. Current Drug Metab 2001, 2:199-214.
44. Verma A., Hirsch D.J., Glatt C.E., Ronnett G.V., Snyder S.H. Carbon monoxide: a putative neural messenger. Science 1993, 259:381-384.
45. Weng Y., DiRusso C.C., Reilly A.A., Black P.N., Ding X. Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype. J Biol Chem 2005, 280:31686-31698.
46. Weng Y., Fang C., Turesky R.J., Behr M., Kaminsky L.S., Ding X. Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice. Cancer Res 2007, 67:7825-7832.
47. Wu L., Gu J., Weng Y., Kluetzman K., Swiatek P., Behr M., Zhang Q.Y., Zhuo X., Xie Q., Ding X. Conditional knockout of the mouse NADPH-cytochrome P450 reductase gene. Genesis 2003, 36:177-181.
48. Yau J.L., Noble J., Graham M., Seckl J.R. Central administration of a cytochrome P450-7B product 7 alpha-hydroxypregnenolone improves spatial memory retention in cognitively impaired aged rats. J Neurosci 2006, 26:11034-11040.
49. Zhang Q.Y., Fang C., Zhang J., Dunbar D., Kaminsky L., Ding X. An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine. Drug Metab Dispos 2009, 37:651-657.
50. Zhuo M., Laitinen J.T., Li X.C., Hawkins R.D. On the respective roles of nitric oxide and carbon monoxide in long-term potentiation in the hippocampus. Learn Mem 1999, 6:63-76.
51. Zwain I.H., Yen S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 1999, 140:3843-3852.